CARDEAS PHARMA CORP

Profile

Company Names

CARDEAS PHARMA CORP

Addresses

2025 1ST AVENUE, SUITE 1200, SEATTLE, WA 98121

2025 FIRST AVENUE, SUITE 1200, SEATTLE, WA 98121

2518 EASTLAKE AVENUE EAST, SUITE 300, SEATTLE, WA 98102

Phone Numbers

206-973-1026
206-336-5550

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$49,048,824.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-05-17 
$37,500,000.00 
$37,500,000.00 
$0.00 
Equity 
3
2011-12-19 
$10,527,201.00 
$10,535,985.00 
$8,784.00 
Equity 
2
2011-02-10 
$1,001,523.00 
$1,100,000.00 
$98,477.00 
Equity 
1
2010-08-01 
$20,100.00 
$20,100.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AARON 
 
DAVIDSON 
DIRECTOR
HYPERBRANCH MEDICAL TECHNOLOGY INC   |  GEMIN X PHARMACEUTICALS INC   |  QUINNOVA PHARMACEUTICALS, INC.   |  NEURAXON(USA), INC.   |  TRANZYME INC   |  INTACT VASCULAR, INC.   |  CARDEAS PHARMA CORP   |  FORSIGHT VISION5, INC.   |  CONAVI MEDICAL CORP.   |  PERIMETER MEDICAL IMAGING AI, INC.
ROBERT 
 
DEGAVRE 
DIRECTOR
CARDIAC INSIGHT, INC.   |  CARDEAS PHARMA CORP
STEPHEN 
 
GRAHAM 
EXECUTIVE OFFICER
CARDEAS PHARMA CORP   |  CERVEL NEUROTECH, INC.
KEVIN 
 
KINSELLA 
DIRECTOR
SIRION HOLDINGS, INC.   |  SIRION HOLDINGS, INC.   |  REVISION THERAPEUTICS, INC.   |  ANAPTYSBIO INC   |  CARDEAS PHARMA CORP   |  JULIET MARINE SYSTEMS, INC.   |  ANKASA REGENERATIVE THERAPEUTICS, INC.   |  EIKONIZO THERAPEUTICS, INC.
PETER 
 
MOLDT 
DIRECTOR
CARDEAS PHARMA CORP   |  ALLAKOS INC.   |  BIOCLIN THERAPEUTICS, INC.   |  CORVUS PHARMACEUTICALS, INC.   |  VASCULOX, INC.   |  E-SCAPE BIO, INC.   |  TIOMA THERAPEUTICS, INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  VIEWPOINT THERAPEUTICS, INC.   |  OUTPOST MEDICINE, LLC   |  SWIFT HEALTH SYSTEMS INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCAPE BIO, INC.   |  AVALYN PHARMA INC.
A. 
BRUCE 
MONTGOMERY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CARDEAS PHARMA CORP   |  AVALYN PHARMA INC.   |  XENCOR INC
ANTHONY 
 
SCULLION 
DIRECTOR
CARDEAS PHARMA CORP
MELISSA 
 
YEAGER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CARDEAS PHARMA CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-04-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-17 
2013-05-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-17 
2012-09-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-19 
2012-03-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-19 
2011-12-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-19 
2011-02-22
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-10 
2010-08-10
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#